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The activity of smooth and non-muscle myosin II is regulated by phosphoryla-
tion of the regulatory light chain (RLC) at ser19. The dephosphorylated state
of full-length monomeric myosin is characterized by an asymmetric intramo-
lecular head-head interaction that completely inhibits the ATPase activity,
accompanied by a hairpin fold of the tail, which prevents filament assembly.
The mechanism by which ser19 phosphorylation disrupts these head-head
interactions is unknown. Computational modeling (Tama et al., 2005. J. Mol.
Biol. 345, 837-854) suggested that formation of the inhibited state is character-
ized by both torsional and bending motions about the myosin heavy chain (HC)
at a location between the RLC and the essential light chain (ELC). Based on
this model, placement of the regulatory domain at this locus might alter relative
motions between the ELC and the RLC and thereby disrupt the inhibited state.
Here we derive an atomic model based on this hypothesis for the phosphory-
lated state of the smooth muscle myosin light chain domain (LCD). We use
a homology model for the structure of the RLC and a largely a-helical structure
for the regulatory domain. This model predicts a set of specific interactions
between the regulatory domain and both the myosin HC and the ELC. Site
directed mutagenesis combined with ATPase and motility assays was used to
show that interactions between the highly basic N-terminus of the RLC with
acidic residues on helix-A of the ELC are required for phosphorylation to acti-
vate smooth muscle myosin. These sites are well conserved in all the myosin II
ELC sequences examined despite the lack of known interacting partners and
when substituted, are usually substituted with aspartic acid. Supported by
NIH grants AR47421, AR53975 and HL38113 and RR12255.
3675-Pos Board B403
Dependence of the Rate of Phosphate Dissociation from Actomyosin-ADP-
Pi Upon the Alkali Light Chains in Skeletal Muscle Myosin
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The A1 light chain of rabbit skeletal myosin possesses a unique N-terminal
extension of ~40 amino acids which is lacking in A2. A C-terminal block of
~140 amino acids is identical to both. The primary structures are completed
by a small, non-identical peptide which is sandwiched between the above
two sections of A1 and which is N-terminal in A2. The effect which A1 and
A2 have on the product release step has been investigated by double-mixing
stopped-flow in conjunction with a fluorescent phosphate binding protein
(Buffer, 5mM MOPS, 2mM Mg acetate, pH 7). Rabbit skeletal myosin-S1
was chromatographically separated into A1 and A2 containing fractions. A
slight excess of myosin-S1 over nucleotide was used in the first mix to ensure
complete binding of the latter as well as a single turnover. After a 2 s delay to
assure that ATP binding was complete, thin filaments (þCa) were combined
with the myosin-nucleotide mixture (M-ATP Uˆ M-ADP-Pi) in the second
mix. The dominant component of the observed biphasic increase in fluores-
cence corresponds to Pi release from AM-ADP-Pi. Hyperbolic fits of the depen-
dence of the rate upon the thin filament give maximum rates of: 80 s-1 (S1A1)
and 139 s-1 (S1A2) and apparent binding constants of 10 mM (S1A1) and 72
mM (S1A2). The rates of phosphate dissociation are 4-5 more rapid than the
steady state measurements of 20 s-1 (A1) and 36 s-1 (A2) and therefore cannot
limit the rate of ATP hydrolysis. It is also evident that the N-terminal extension
strengthens light chain affinity.
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The R21C mutation in cTnI, associated with hypertrophic cardiomyopathy
(HCM), is the only known mutation within N-terminus of cTnI. The mecha-
nisms by which this mutation leads to heart failure, and how this mutationaffects PKA regulation of cTn function and myofibril relaxation still remain
elusive. Currently, we are studying this mutation using an integrated
experimental-computational approach. We generated triple-mutated cTnI
(cTnI-R21C/S2324D) to mimic the phosphorylation. From steady-state fluores-
cence measurement, which using a fluorescent probe (IANBD) coupled to
cTnCC35S, C-I binding affinity (KC-I) and calcium binding affinity (KCa) to
whole cTn were monitored. cTnIR21C increased both KC-I and KCa compared
to cTnIWT. Phosphorylation of cTnI reduced KCa for both complexes. However,
while PKA treatment weakened KC-I for cTnI
WT, this effect was not absent in
cTnIR21C. To study myofibril contraction/relaxation mechanics and kinetics,
endogenous cTn was exchanged with either WT or R21C recombinant cTn,
and mechanics were monitored at maximum and submaximal Ca2þ conditions.
The kinetics of activation (KACT) is slower at submaximal vs maximal Ca
2þ
conditions, and not affected by PKA treatment of myofibrils containing either
cTnIWT or cTnIR21C. However, PKA treatment of cTn with cTnIWT signifi-
cantly affected slow phase relaxation, increasing slow phase rate (KREL,slow)
and decreasing slow phase duration (tREL, slow), and these effects are more clear
at submaximal calcium levels. Interestingly, these PKA mediated effects
were blunted in cTnIR21C. Molecular dynamics (MD) simulations of whole
cTn with R21C and R21C/S23DS24D substitution are ongoing. Interactions
between cNTnC-cNTnI, cNTnC-switch peptide of cTnI, and cTnC-inhibitory
peptide of cTnI will be monitored, and calcium binding sites will be studied.
Computational results will provide the structural basis at molecular level
of how R21C influence C-I binding and relaxation of cardiac muscles.
HL65497, HL11197 (MR), 8P41GM103426 (AM & AM).
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Actin-Activated Atpase and Actin Sliding Velocities are Similarly
Influenced by Actin-Myosin Binding Kinetics
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Detachment-limited models of muscle shortening assume that with increasing
myosin densities maximal velocities are achieved when at least one myosin
head is bound to a given actin filament. However, numerous studies suggest
that actin sliding velocities, V, are influenced by actin-myosin attachment
kinetics, suggesting that V should saturate - along with actin-activated myosin
ATPase activity, v - when myosin heads saturate binding sites on actin. Here we
used an in vitro motility assay to measure both V and v in the same flow cell.
We observed that both V and v exhibited similar saturation kinetics with
increasing myosin densities and that increasing ionic strength similarly
decreased the Km for both activation curves. Using the same in vitro assay,
we measured the calcium-dependence of V for regulated thin filaments (actin
filaments reconstituted with tropomyosin and troponin) and observed that
the myosin-dependence of calcium sensitivity (pCa50) exhibited saturation
kinetics similar to that of V and v. These results suggest that saturation of
V, v, and pCa50 all occur when myosin saturates binding sites on actin. This
is consistent with estimates showing that saturating myosin densities in a
motility assay correspond to a linear spacing of myosin along an actin filament
that is similar to the repeat of myosin binding sites along one side of the
filament.
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Effects of EMD57033 and EGCG on Modulation of Ca2D-Sensitivity by
Pka Phosphorylation
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HCM and DCM-causing mutations alter myofilament Ca2þ-sensitivity but
many also uncouple the phosphorylation of Ser 22 and 23 of cardiac troponin
I from the change in Ca2þ-sensitivity.
We studied the effects of small molecules that also modulate Ca2þ-sensitivity
using single thin filaments containing human cardiac troponin in the in vitro
motility assay.
EMD57033 is a Ca2þ-sensitiser and causes a dose dependent increase in Ca2þ-
sensitivity (optimum at 30mM). The increase in Ca2þ-sensitivity was 2-fold for
fraction motile and 5-fold for motile velocity. EMD57033 increased Ca2þ-
sensitivity in wild-type, in DCM mutations (TPM1 E40K and E54K) and in
troponin from myectomy samples. In addition, in wild-type, Ca2þ-sensitivity
becomes independent of troponin I phosphorylation, this uncoupling resembles
the effect of HCM mutations.
Epigallocatechin 3-Gallate (EGCG) is a Ca2þ-desensitiser, 100mM reduces
Ca2þ-sensitivity of native human thin filaments by 1.5-fold. The maximum
sliding speed was reduced as well. EGCG also decreased Ca2þ-sensitivity in
thin filaments with DCM mutations (TPM1 E40K and E54K, 1.3- and 3.5-
fold respectively) and in troponin from myectomy samples (1.6-fold).
